2024-04-01 2025-03-31 2025-03-31 false 13813709 DIAMOND COSMETIC CLINIC LIMITED 2026-01-09 false iso4217:GBP xbrli:pure 13813709 2024-03-31 13813709 2025-03-31 13813709 2024-04-01 2025-03-31 13813709 2023-03-31 13813709 2024-03-31 13813709 2023-04-01 2024-03-31 13813709 bus:SmallEntities 2024-04-01 2025-03-31 13813709 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 13813709 bus:FullAccounts 2024-04-01 2025-03-31 13813709 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13813709 core:WithinOneYear 2025-03-31 13813709 core:AfterOneYear 2025-03-31 13813709 core:WithinOneYear 2024-03-31 13813709 core:AfterOneYear 2024-03-31 13813709 core:ShareCapital 2025-03-31 13813709 core:SharePremium 2025-03-31 13813709 core:RevaluationReserve 2025-03-31 13813709 core:OtherReservesSubtotal 2025-03-31 13813709 core:RetainedEarningsAccumulatedLosses 2025-03-31 13813709 core:ShareCapital 2024-03-31 13813709 core:SharePremium 2024-03-31 13813709 core:RevaluationReserve 2024-03-31 13813709 core:OtherReservesSubtotal 2024-03-31 13813709 core:RetainedEarningsAccumulatedLosses 2024-03-31 13813709 core:LandBuildings 2025-03-31 13813709 core:PlantMachinery 2025-03-31 13813709 core:Vehicles 2025-03-31 13813709 core:FurnitureFittings 2025-03-31 13813709 core:OfficeEquipment 2025-03-31 13813709 core:NetGoodwill 2025-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 13813709 core:ListedExchangeTraded 2025-03-31 13813709 core:UnlistedNon-exchangeTraded 2025-03-31 13813709 core:LandBuildings 2024-03-31 13813709 core:PlantMachinery 2024-03-31 13813709 core:Vehicles 2024-03-31 13813709 core:FurnitureFittings 2024-03-31 13813709 core:OfficeEquipment 2024-03-31 13813709 core:NetGoodwill 2024-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 13813709 core:ListedExchangeTraded 2024-03-31 13813709 core:UnlistedNon-exchangeTraded 2024-03-31 13813709 core:LandBuildings 2024-04-01 2025-03-31 13813709 core:PlantMachinery 2024-04-01 2025-03-31 13813709 core:Vehicles 2024-04-01 2025-03-31 13813709 core:FurnitureFittings 2024-04-01 2025-03-31 13813709 core:OfficeEquipment 2024-04-01 2025-03-31 13813709 core:NetGoodwill 2024-04-01 2025-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 13813709 core:ListedExchangeTraded 2024-04-01 2025-03-31 13813709 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 13813709 core:MoreThanFiveYears 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments 2025-03-31 13813709 core:Non-currentFinancialInstruments 2024-03-31 13813709 dpl:CostSales 2024-04-01 2025-03-31 13813709 dpl:DistributionCosts 2024-04-01 2025-03-31 13813709 core:LandBuildings 2024-04-01 2025-03-31 13813709 core:PlantMachinery 2024-04-01 2025-03-31 13813709 core:Vehicles 2024-04-01 2025-03-31 13813709 core:FurnitureFittings 2024-04-01 2025-03-31 13813709 core:OfficeEquipment 2024-04-01 2025-03-31 13813709 dpl:AdministrativeExpenses 2024-04-01 2025-03-31 13813709 core:NetGoodwill 2024-04-01 2025-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2024-04-01 2025-03-31 13813709 dpl:GroupUndertakings 2024-04-01 2025-03-31 13813709 dpl:ParticipatingInterests 2024-04-01 2025-03-31 13813709 dpl:GroupUndertakings core:ListedExchangeTraded 2024-04-01 2025-03-31 13813709 core:ListedExchangeTraded 2024-04-01 2025-03-31 13813709 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 13813709 core:UnlistedNon-exchangeTraded 2024-04-01 2025-03-31 13813709 dpl:CostSales 2023-04-01 2024-03-31 13813709 dpl:DistributionCosts 2023-04-01 2024-03-31 13813709 core:LandBuildings 2023-04-01 2024-03-31 13813709 core:PlantMachinery 2023-04-01 2024-03-31 13813709 core:Vehicles 2023-04-01 2024-03-31 13813709 core:FurnitureFittings 2023-04-01 2024-03-31 13813709 core:OfficeEquipment 2023-04-01 2024-03-31 13813709 dpl:AdministrativeExpenses 2023-04-01 2024-03-31 13813709 core:NetGoodwill 2023-04-01 2024-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2023-04-01 2024-03-31 13813709 dpl:GroupUndertakings 2023-04-01 2024-03-31 13813709 dpl:ParticipatingInterests 2023-04-01 2024-03-31 13813709 dpl:GroupUndertakings core:ListedExchangeTraded 2023-04-01 2024-03-31 13813709 core:ListedExchangeTraded 2023-04-01 2024-03-31 13813709 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 13813709 core:UnlistedNon-exchangeTraded 2023-04-01 2024-03-31 13813709 core:NetGoodwill 2025-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2025-03-31 13813709 core:LandBuildings 2025-03-31 13813709 core:PlantMachinery 2025-03-31 13813709 core:Vehicles 2025-03-31 13813709 core:FurnitureFittings 2025-03-31 13813709 core:OfficeEquipment 2025-03-31 13813709 core:AfterOneYear 2025-03-31 13813709 core:WithinOneYear 2025-03-31 13813709 core:ListedExchangeTraded 2025-03-31 13813709 core:UnlistedNon-exchangeTraded 2025-03-31 13813709 core:ShareCapital 2025-03-31 13813709 core:SharePremium 2025-03-31 13813709 core:RevaluationReserve 2025-03-31 13813709 core:OtherReservesSubtotal 2025-03-31 13813709 core:RetainedEarningsAccumulatedLosses 2025-03-31 13813709 core:NetGoodwill 2024-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2024-03-31 13813709 core:LandBuildings 2024-03-31 13813709 core:PlantMachinery 2024-03-31 13813709 core:Vehicles 2024-03-31 13813709 core:FurnitureFittings 2024-03-31 13813709 core:OfficeEquipment 2024-03-31 13813709 core:AfterOneYear 2024-03-31 13813709 core:WithinOneYear 2024-03-31 13813709 core:ListedExchangeTraded 2024-03-31 13813709 core:UnlistedNon-exchangeTraded 2024-03-31 13813709 core:ShareCapital 2024-03-31 13813709 core:SharePremium 2024-03-31 13813709 core:RevaluationReserve 2024-03-31 13813709 core:OtherReservesSubtotal 2024-03-31 13813709 core:RetainedEarningsAccumulatedLosses 2024-03-31 13813709 core:NetGoodwill 2023-03-31 13813709 core:IntangibleAssetsOtherThanGoodwill 2023-03-31 13813709 core:LandBuildings 2023-03-31 13813709 core:PlantMachinery 2023-03-31 13813709 core:Vehicles 2023-03-31 13813709 core:FurnitureFittings 2023-03-31 13813709 core:OfficeEquipment 2023-03-31 13813709 core:AfterOneYear 2023-03-31 13813709 core:WithinOneYear 2023-03-31 13813709 core:ListedExchangeTraded 2023-03-31 13813709 core:UnlistedNon-exchangeTraded 2023-03-31 13813709 core:ShareCapital 2023-03-31 13813709 core:SharePremium 2023-03-31 13813709 core:RevaluationReserve 2023-03-31 13813709 core:OtherReservesSubtotal 2023-03-31 13813709 core:RetainedEarningsAccumulatedLosses 2023-03-31 13813709 core:AfterOneYear 2024-04-01 2025-03-31 13813709 core:WithinOneYear 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:CostValuation 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-04-01 2025-03-31 13813709 core:Non-currentFinancialInstruments core:CostValuation 2025-03-31 13813709 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-03-31 13813709 core:Non-currentFinancialInstruments core:CostValuation 2024-03-31 13813709 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-03-31 13813709 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-03-31 13813709 bus:Director1 2024-04-01 2025-03-31

DIAMOND COSMETIC CLINIC LIMITED

Registered Number
13813709
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

DIAMOND COSMETIC CLINIC LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Director | Dr Humza Umar

Registered Address | Fulford Lodge
| 1 Heslington Lane
| Fulford
| YO10 4HW

Registered Number | 13813709 (England and Wales)

DIAMOND COSMETIC CLINIC LIMITED
Statement of Financial Position
31 March 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Current assets |  |  |  |  |  |  |  |
Debtors | 3 | 16,319 |  |  |  | 13,711 |  |
Cash at bank and on hand |  | 71,621 |  |  |  | 61,149 |  |
|  | 87,940 |  |  |  | 74,860 |  |
Creditors amounts falling due within one year | 4 | (55,176) |  |  |  | (42,397) |  |
Net current assets (liabilities) |  |  |  | 32,764 |  |  |  | 32,463
Total assets less current liabilities |  |  |  | 32,764 |  |  |  | 32,463
Net assets |  |  |  | 32,764 |  |  |  | 32,463
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 32,664 |  |  |  | 32,363
Shareholders' funds |  |  |  | 32,764 |  |  |  | 32,463

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 9 January 2026, and are signed on its behalf by:
Dr Humza Umar Director Registered Company No. 13813709

DIAMOND COSMETIC CLINIC LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| These financial statements have been prepared in compliance with FRS 102 Section 1A, The Financial Reporting Standard applicable in the UK and Republic of Ireland.

| Basis of preparation
--- | ---
| The financial statements have been prepared on the historical cost basis.

| Going concern
--- | ---
| The UK economy has recently been impacted by rising inflation, interest rates and energy costs, exacerbated by the war in Ukraine. All these matters have impacted the company's trading results to a greater or lesser extent. At the date of signing these financial statements, the directors have considered the effect of these matters on the company with the information available to it and do not believe that it will affect the ability of the company to continue to trade for the foreseeable future. On this basis, the directors have prepared these financial statements on a going concern basis.

| Turnover policy
--- | ---
| The revenue shown in the profit and loss account represents income receivable from dental treatments carried out during the period. Revenue in respect of dental treatment uncompleted at the year end date is recognised by reference to the state of completion.

| Current taxation
--- | ---
| The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amount of tax expected to pay or recover using the tax rates and laws that have been enacted, or substantively enacted, at the reporting date.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 0 |  | 0

3. | Debtors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade debtors / trade receivables | 16,319 |  | 13,711
| Total | 16,319 |  | 13,711

4. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Amounts owed to related parties | 901 |  | 301
| Taxation and social security | 53,054 |  | 41,016
| Accrued liabilities and deferred income | 1,221 |  | 1,080
| Total | 55,176 |  | 42,397

5. | Related party transactions
--- | ---
| During the year the directors made available a loan to the company of £901 (2024: £301). Interest has been charged on this balance at the UK market rate. The loan is repayable on demand